A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 (2012)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2012.06.052
- Subjects: COLESTEROL (ANÁLISE); CORONARIOPATIA (PATOLOGIA); DISLIPIDEMIAS (ETIOLOGIA); FATORES DE RISCO; LIPOPROTEÍNAS (ANÁLISE)
- Language: Inglês
- Imprenta:
- Source:
- Título: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 224, n. 1, p. 150-153, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS, Raul D. et al. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2. Atherosclerosis, v. 224, n. 1, p. 150-153, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2012.06.052. Acesso em: 24 fev. 2026. -
APA
Santos, R. D., Waters, D. D., Tarasenko, L., Messig, M., Jukema, J. W., Chiang, C. -W., et al. (2012). A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2. Atherosclerosis, 224( 1), 150-153. doi:10.1016/j.atherosclerosis.2012.06.052 -
NLM
Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Chiang C-W, Ferrieres J, Foody JAM. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 [Internet]. Atherosclerosis. 2012 ; 224( 1): 150-153.[citado 2026 fev. 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2012.06.052 -
Vancouver
Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Chiang C-W, Ferrieres J, Foody JAM. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 [Internet]. Atherosclerosis. 2012 ; 224( 1): 150-153.[citado 2026 fev. 24 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2012.06.052 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1016/j.atherosclerosis.2012.06.052 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
